A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
2014 · Clinical Infectious Diseases · 221 citations
https://doi.org/10.1093/cid/ciu219
A
Alejandro Rodríguez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
432
Papers
12.4K
Citations
59
h-index
183
i10-index
Alejandro Rodríguez is an academic researcher from Brigham Young University. The author has contributed to research in topics: Pneumonia and Respiratory Infections & Sepsis Diagnosis and Treatment & Nosocomial Infections in ICU. The author has an h-index of 59, co-authored 368 publications.
ORCID: 0000-0001-8828-5984Papers by this author
worksCorticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
2018 · Intensive Care Medicine · 165 citations
https://doi.org/10.1007/s00134-018-5332-4
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
2021 · Intensive Care Medicine · 158 citations
https://doi.org/10.1007/s00134-021-06449-4
Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions
2016 · Critical Care · 105 citations
https://doi.org/10.1186/s13054-016-1324-3
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
2021 · Critical Care · 92 citations
https://doi.org/10.1186/s13054-021-03487-8
Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis
2016 · Cytokine · 77 citations
https://doi.org/10.1016/j.cyto.2016.08.028
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat